Clinical Trial Update: Vismodegib and Gemcitabine Hydrochloride in Treating Patients With Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update reports results for the combination of vismodegib and gemcitabine hydrochloride in advanced pancreatic cancer (recurrent or s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine hydrochloride (Gemcitabine hydrochloride)
• Vismodegib (Vismodegib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Pancreatic Carcinoma, Stage IV Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-10-07